Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Drug Discovery Technologies Global Market Opportunities And Strategies To 2033
... Companies; Biopharmaceutical Companies; Biotechnology Companies; Research Institutes4) By Disease Application: Cancer Diseases; Immunological Diseases; Neurological Diseases; Cardiovascular DiseasesCovering: AstraZeneca plc.; Merck KGaA; GlaxoSmithKline Plc; Pfizer Inc.; Thermo Fisher Scientific Drug Discovery Technologies Global Market Opportunities ... Read More
-
Microscopy Market Size, Share & Trends by Product (Microscope, Software, Accessories), Type (Optical (Stereo, Confocal), Electron (SEM, TEM, Cryo-EM), AFM, STM), End User (Semiconductor, Academia, Life Science: Diagnostic, Drug Discovery, MFG) - Region Global Forecast to 2029
... to 2029 The global microscopy market is estimated to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, at a CAGR of 5.4% during the forecast period of 2024 to 2029. The ... Read More
-
Global Cancer Immunotherapy Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Liver Cancer Drugs
... by 2030, growing at a CAGR of 18.4% over the analysis period 2023-2030. Targeted Drug Therapy, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$5.1 Billion ... Read More
-
Inflammatory Bowel Disease (IBD) Therapeutics
... is expected to reach US$32.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. TNF inhibitors, one of the segments analyzed in the report, is expected to record a 5.9% ... Read More
-
Global Schizophrenia Drugs Market Report by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Treatment (Injectable, Oral) Therapeutic Class (Second Generation, Third Generation, Others) Countries and Company Analysis, 2024-2032
... drugs market will increase from US$ 7,433.1 million in 2030 to over US$ 10,132.4 million by 2032 with a CAGR of 3.50% from 2024 to 2032. This growth is as a result of the growing ... Read More
-
High Content Screening (HCS)
... reach US$2.2 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. HCS Instruments, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Biosimulation Technology
... at a CAGR of 15.7% over the analysis period 2023-2030. Biosimulation Software, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$5.7 Billion by the end of ... Read More
-
Acute Heart Failure (AHF) Therapeutics
... is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 21.3% over the analysis period 2023-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.8% ... Read More
-
Bipolar Disorder Therapeutics
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by ... Read More
-
Cancer Cachexia
... at a CAGR of 5.6% over the analysis period 2023-2030. Progestogens Therapeutics, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Pathology Instruments
... at a CAGR of 5.6% over the analysis period 2023-2030. Molecular Diagnostics Technology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the end ... Read More
-
Osteoporosis Therapeutics
... at a CAGR of 2.8% over the analysis period 2023-2030. Bisphosphonates Drug Class, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$8.1 Billion by the end ... Read More
-
Drug Discovery Technologies
... by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. Small Molecule Drugs Discovery Technologies, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach ... Read More
-
Chiral Technology
... at a CAGR of 3.8% over the analysis period 2023-2030. Intermediates, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$8.2 Billion by the end of the ... Read More
-
Janus Kinase (JAK) Inhibitor- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Synthetic Biology
... at a CAGR of 28.0% over the analysis period 2023-2030. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is expected to record a 29.3% CAGR and reach US$39.5 Billion by the ... Read More
-
Narcolepsy Therapeutics
... at a CAGR of 7.2% over the analysis period 2023-2030. Narcolepsy with Cataplexy Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion by the ... Read More
-
Huntington`s Disease Therapeutics
... by 2030, growing at a CAGR of 31.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$787.6 Million While China is Forecast to Grow at 40.2% CAGR The Huntington`s Disease Therapeutics market ... Read More
-
Testosterone Replacement Therapy (TRT)
... reach US$2.5 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. TRT Topicals, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach ... Read More
-
Irritable Bowel Syndrome (IBS) Therapeutics
... is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. IBS-D Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% ... Read More
-
Fibromyalgia Therapeutics
... at a CAGR of 3.0% over the analysis period 2023-2030. Antiepileptics Drug Class, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$2.1 Billion by the end ... Read More
-
Apoptosis
... of 4.6% over the analysis period 2023-2030. Apoptosis Assay Kits, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.9 Billion by the end of the analysis ... Read More
-
Advanced Wound Care (AWC) - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Devices [Negative Pressure Wound Therapy Devices, Hyperbaric Oxygen Therapy Devices, Debridement Devices, and Others], Grafts & Matrices), Wound Type (Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Burns, Others), End-User (Hospitals, Specialty Clinics, and Others), and ... Read More
-
Anemia Drugs
... at a CAGR of 4.1% over the analysis period 2023-2030. Iron Deficiency Anemia Drugs, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the ... Read More
Research Assistance
